2022
COMUNICATO STAMPA – Waldo Mossi eletto Vicepresidente di Farma Industria Ticino per il triennio 2022-2025
Comunicato Stampa “Farma Industria Ticino and Credit Suisse Award for best student”
![](https://www.farmaindustriaticino.ch/files/2017/02/logo_helsinn-160x160.png)
Helsinn Healthcare SA signs exclusive license agreement with Juniper Biologics Pte. Ltd. for LEDAGA® (chlormethine) in Australia, Asia and the Middle East*
![](https://www.farmaindustriaticino.ch/files/2017/02/logo_helsinn-160x160.png)
Helsinn presents newly available data on vepafestinib at IASLC 2022 World Conference on Lung Cancer
![](https://www.farmaindustriaticino.ch/files/2015/05/logo_ibsa-160x160.png)
LOCARNO FILM FESTIVAL 2022 CINEMA E SOSTENIBILITÀ AMBIENTALE: IBSA È ANCORA OFFICIAL CLIMATE ACTION PROMOTER DELLA KERMESSE CINEMATOGRAFICA
![](https://www.farmaindustriaticino.ch/files/2022/07/Venture-Leaders-biotech-2022-160x160.jpg)
Venture Leaders Biotech 2022: 10 innovative startups will advance their global growth in Boston – Healiva is among the 10 startups chosen
![](https://www.farmaindustriaticino.ch/files/2022/07/18-IBSA-160x160.jpg)
ACCORDO IBSA-CHOOSE LIFE BIOTECH: NUOVE AREE DI RICERCA PER AMPLIARE LE PROSPETTIVE TERAPEUTICHE NELL’AMBITO DELL’IMMUNOTERAPIA
Comunicato stampa – Piero Poli nuovo Presidente di FIT
![](https://www.farmaindustriaticino.ch/files/2017/02/logo_helsinn-160x160.png)
Linkedin